EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
82 hedge funds and large institutions have $40.8M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 24 reducing their positions, and 38 closing their positions.
Holders
82
Holders Change
-22
Holders Change %
-21.15%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
20
Reduced
24
Closed
38
Calls
$2.59M
Puts
$1.29M
Net Calls
+$1.3M
Net Calls Change
+$1.46M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$4.67M |
| 2 |
2
D.E. Shaw & Co
New York
|
$5.13M |
| 3 |
3
Millennium Management
New York
|
$4.15M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$7.92M |
| 5 |
5
Renaissance Technologies
New York
|
$1.7M |
